Gastric bypass is a surgical procedure used to reduce the stomach size, and decrease its food storage capacity. Common bariatric surgery procedures to reduce the stomach size are gastric bypass, adjustable gastric band, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch. During the gastric bypass, the stomach is divided into upper and lower pouch due to which is food directly enters the small intestine after passing through the stomach. The surgery is found to be an effective treatment for obesity, i.e. BMI greater than 40. Other indication for gastric bypass gastroesophageal reflux disease, heart disease, high blood pressure, and type 2 diabetes.

The rising prevalence of obesity, diabetes and cardiovascular disease, and increasing demand for minimally invasive surgery are majorly driving the growth of the market across the globe. Additionally, use of advanced technology devices for a surgical procedure in health care institutes also influence the market growth.

Furthermore, globalization in the healthcare has influenced the market growth. Established market players in the developed countries tap new markets through new products and services into the developing regions and emerging economies. The major strategic approach followed by the company is a geographical expansion and product launch for sustaining growth in the market. However, side effects of the gastric bypass may hamper the market growth during the forecast period.

The Global Gastric Bypass Market is expected to grow at a CAGR of 6.1% during the forecast period 2017-2023.

The Americas are the largest gastric bypass market across the globe owing to well-developed technology, increasing the prevalence of obesity and cardiovascular diseases, availability of healthcare specialty healthcare services, and technologically advancement in the field of healthcare. In North America, the U.S. dominates the market owing to an increased number of market players manufacturing surgical devices. Additionally, in the U.S., gastric bypass is one of the most common procedures for obesity, and other major indications such as diabetes, and gastroesophageal reflux disease. Furthermore, the prevalence of diabetes is found to be increasing among the U.S. population. As per the National Diabetes Statistics Report of the Center for Disease Control and Prevention (CDC), in 2015, 9.4% of the U.S. population i.e. 30.3 million people had diabetes.

Europe holds the second position in the global gastric bypass market owing to the increasing diabetic population. Additionally, extensive research & development activities in the field of gastroenterology and availability of funds for research also fuel the market growth. Germany and France are the largest contributors to the market owing to increasing use of minimally invasive surgical procedures in hospitals, and surgical centers.

The Asia Pacific is the fastest growing gastric bypass market owing to the ever-increasing prevalence of diabetes and cardiovascular diseases and demand for technologically advanced devices for minimally invasive surgical procedures. India and China are the major contributors to large diabetic patient pool and increasing number of specialty services. Additionally, the growth of the medical technology and healthcare industry in developing economies of Asia Pacific also influence the growth of the market. Furthermore, increasing demand for quality care services and new devices in the healthcare are expected to increase the use of advanced medical devices and instruments.

In the Middle East & Africa, prevalence of obesity and diabetes is increasing from last few years. This increase in the prevalence is attributed to sedentary lifestyle, and lack of physical exercise. In Africa, the prevalence of non-communicable diseases is increasing at a steady rate along with communicable diseases, thus signifying the need for effective therapeutic options of treatment of diseases.